Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder	Active, not recruiting	Phase 2	2026-06-10		NCT04587128

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Doris Duke Charitable Foundation	18
University of Wisconsin, Madison	265

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Wisconsin Carbone Cancer Center	Madison	United States	58

Clinical trials